ELOXX PHARMACEUTICALS, INC. Property, Plant and Equipment
ELOXX PHARMACEUTICALS, INC. (ELOX) had Property, Plant and Equipment of $0 as of 2025-12-31, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-09-11
- 2025-12-31: Property, Plant and Equipment, Net $0.00.
- 2024-12-31: Property, Plant and Equipment, Net $0.00.
- 2023-12-31: Property, Plant and Equipment, Net $35.00K.
- 2023-09-30: Property, Plant and Equipment, Net $107.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2025-12-31 | $0.00 S-1 · filed 2026-09-11 | |
| 2024-12-31 | $0.00 S-1 · filed 2026-09-11 | |
| 2023-12-31 | $35.00K S-1 · filed 2026-09-11 | |
| 2023-09-30 | $107.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $130.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $143.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $169.00K 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $215.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $190.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $206.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $216.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $224.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $185.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $117.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $133.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $149.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $165.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $182.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $201.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $220.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $214.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $231.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $248.00K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $345.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $302.00K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $314.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $278.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $42.77K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $50.98K 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $60.15K 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $41.00K 10-K · filed 2018-03-16 | $67.05K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $80.92K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $92.55K 10-K · filed 2017-10-13 | |
| 2016-03-31 | $105.36K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $124.30K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $153.85K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $185.95K 10-K · filed 2016-10-13 | |
| 2015-03-31 | $226.75K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $259.28K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $262.63K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $223.47K 10-K · filed 2015-10-09 | |
| 2014-03-31 | $2.99K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $3.51K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $4.03K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $4.55K 10-K · filed 2014-09-29 | |
| 2013-03-31 | $5.20K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $5.85K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $6.49K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $5.86K 10-K · filed 2013-09-11 | |
| 2012-03-31 | $6.45K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $7.05K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $3.32K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.78K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |